{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-068026","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2026-06-12T13:09:14+00:00","discovered_at":"2026-06-12T13:10:00.246516+00:00","generated_at":"2026-06-12T13:10:09.255604+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BiomX wins NYSE American approval of compliance plan; has until Sep 2027","bullets":["NYSE American accepted BiomX's plan to regain compliance; plan period ends Sept 25, 2027.","Non-compliance stems from stockholders' deficit of $(1.302M) as of Dec 31, 2025.","Company continues trading on NYSE American with .BC indicator during plan period.","Plan submitted Apr 24, 2026; periodic NYSE Regulation reviews apply."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-068026","json":"https://secwatch.observer/filing/0001213900-26-068026.json","markdown":"https://secwatch.observer/filing/0001213900-26-068026.md","text":"https://secwatch.observer/filing/0001213900-26-068026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026068026/0001213900-26-068026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026068026/ea0294507-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T13:10:09.255604+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc67e9474f7c7629588d6d1d7b56e8f61b7ab2de","claim":"BiomX Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).","evidence_excerpt":"iod through September 25, 2027 to regain compliance with the applicable continued listing standards. As previously disclosed, on March 25, 2026, the Company received written notice from NYSE Regulation that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the NYSE American LLC Company Guide (the “Company Guide”), which require a listed company to maintain specified levels of stockholders’ equity. The notice was based on the Company’s reported stockholders’ deficit of $(1,302,000) as of December 31, 2025 and","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026068026/0001213900-26-068026-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse american"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"1003(a)(i), 1003(a)(ii), 1003(a)(iii)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}